Hormone therapy and risk of venous thromboembolism among postmenopausal women

Maturitas

Volumn 82, Issue 3, 2015, Pages 304-307

  Canonico, Marianne ^a  

^a CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

Author keywords

Hormone therapy; Postmenopausal women; Venous thromboembolism

Indexed keywords

ACTIVATED PROTEIN C; ESTROGEN; GESTAGEN; NOMEGESTROL ACETATE; PROMEGESTONE; DRUG COMBINATION; ESTRADIOL; PROGESTERONE;

ACTIVATED PROTEIN C RESISTANCE; BLOOD CLOTTING; CARDIOVASCULAR RISK; ESTROGEN THERAPY; HEMOSTASIS; HIGH RISK PATIENT; HORMONAL THERAPY; HUMAN; MENOPAUSAL SYNDROME; POSTMENOPAUSE; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT DURATION; VENOUS THROMBOEMBOLISM; ADVERSE EFFECTS; CHEMICALLY INDUCED; DRUG COMBINATION; FEMALE; INTRADERMAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; RISK ASSESSMENT;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; DRUG COMBINATIONS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; POSTMENOPAUSE; PROGESTERONE; PROGESTINS; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM;

EID: 84945442272     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2015.06.040     Document Type: Review

References (35)

1. E. Oger Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP study group. Groupe d'Etude de la Thrombose de Bretagne Occidentale Thromb. Haemost. 83 May (5) 2000 657 660
2. V. Olie, M. Canonico, and P.Y. Scarabin Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women Curr. Opin. Hematol. 17 September (5) 2010 457 463
3. Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center, N. Engl. J. Med. (1974) 290(1) 15-19.
4. E. Daly, M.P. Vessey, M.M. Hawkins, J.L. Carson, P. Gough, and S. Marsh Risk of venous thromboembolism in users of hormone replacement therapy Lancet 348 October (9033) 1996 977 980
5. H. Jick, L.E. Derby, M.W. Myers, C. Vasilakis, and K.M. Newton Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens Lancet 348 October (9033) 1996 981 983
6. S. Perez Gutthann, L.A. Garcia Rodriguez, J. Castellsague, and A. Duque Oliart Hormone replacement therapy and risk of venous thromboembolism: population based case-control study BMJ 314 March (7083) 1997 796 800
7. P.Y. Scarabin, E. Oger, and G. Plu-Bureau Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk Lancet 362 August (9382) 2003 428 432
8. N.L. Smith, S.R. Heckbert, R.N. Lemaitre, A.P. Reiner, T. Lumley, N.S. Weiss, E.B. Larson, F.R. Rosendaal, and B.M. Psaty Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis JAMA 292 October (13) 2004 1581 1587
9. J.D. Douketis, J.A. Julian, C. Kearon, D.R. Anderson, M.A. Crowther, S.M. Bates, M. Barone, F. Piovella, A.G. Turpie, S. Middeldorp, P. van Nguyen, P. Prandoni, P.S. Wells, M.J. Kovacs, M.R. MacGillavry, L. Costantini, and J.S. Ginsberg Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study J. Thromb. Haemost. 3 May (5) 2005 943 948
10. M. Canonico, E. Oger, G. Plu-Bureau, J. Conard, G. Meyer, H. Levesque, N. Trillot, M.T. Barrellier, D. Wahl, J. Emmerich, and P.Y. Scarabin Estrogen, thromboembolism risk study G. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study Circulation 115 February (7) 2007 840 845
11. R.E. Roach, W.M. Lijfering, F.M. Helmerhorst, S.C. Cannegieter, F.R. Rosendaal, and A. van Hylckama Vlieg The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy J. Thromb. Haemost. 11 January (1) 2013 124 131
12. F. Grodstein, M.J. Stampfer, S.Z. Goldhaber, J.E. Manson, G.A. Colditz, F.E. Speizer, W.C. Willett, and C.H. Hennekens Prospective study of exogenous hormones and risk of pulmonary embolism in women Lancet 348 October (9033) 1996 983 987
13. C. Schneider, S.S. Jick, and C.R. Meier Risk of cardiovascular outcomes in users of estradiol/dydrogesterone or other HRT preparations Climacteric 12 October (5) 2009 445 453
14. M. Canonico, A. Fournier, L. Carcaillon, V. Olie, G. Plu-Bureau, E. Oger, S. Mesrine, M.C. Boutron-Ruault, F. Clavel-Chapelon, and P.Y. Scarabin Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study Arterioscler. Thromb. Vasc. Biol. 30 2 2010 340 345
15. T. Ohira, A.R. Folsom, M. Cushman, R.H. White, P.J. Hannan, W.D. Rosamond, and S.R. Heckbert Reproductive history, hormone replacement, and incidence of venous thromboembolism: the longitudinal investigation of thromboembolism etiology Br. J. Haematol. 149 May (4) 2010 606 612
16. C. Renoux, S. Dell'Aniello, and S. Suissa Hormone replacement therapy and the risk of venous thromboembolism: a population-based study J. Thromb. Haemost. 8 May (5) 2010 979 986
17. S. Sweetland, V. Beral, A. Balkwill, B. Liu, V.S. Benson, M. Canonico, J. Green, and G.K. Reeves Million women study C. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study J. Thromb. Haemost. 10 November (11) 2012 2277 2286
18. D. Grady, N.K. Wenger, D. Herrington, S. Khan, C. Furberg, D. Hunninghake, E. Vittinghoff, and S. Hulley Postmenopausal hormone therapy increases risk for venous thromboembolic disease: the heart and estrogen/progestin replacement study Ann. Intern. Med. 132 May (9) 2000 689 696
19. D.M. Herrington, D.M. Reboussin, K.B. Brosnihan, P.C. Sharp, S.A. Shumaker, T.E. Snyder, C.D. Furberg, G.J. Kowalchuk, T.D. Stuckey, W.J. Rogers, D.H. Givens, and D. Waters Effects of estrogen replacement on the progression of coronary-artery atherosclerosis N. Engl. J. Med. 343 August (8) 2000 522 529
20. C.M. Viscoli, L.M. Brass, W.N. Kernan, P.M. Sarrel, S. Suissa, and R.I. Horwitz A clinical trial of estrogen-replacement therapy after ischemic stroke N. Engl. J. Med. 345 October (17) 2001 1243 1249
21. N. Cherry, K. Gilmour, P. Hannaford, A. Heagerty, M.A. Khan, H. Kitchener, R. McNamee, M. Elstein, C. Kay, M. Seif, and H. Buckley Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial Lancet 360 December (9350) 2002 2001 2008
22. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, M.L. Stefanick, R.D. Jackson, S.A. Beresford, B.V. Howard, K.C. Johnson, J.M. Kotchen, and J. Ockene Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 July (3) 2002 321 333
23. M.R. Vickers, A.H. MacLennan, B. Lawton, D. Ford, J. Martin, S.K. Meredith, B.L. DeStavola, S. Rose, A. Dowell, H.C. Wilkes, J.H. Darbyshire, and T.W. Meade Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women BMJ 335 August (7613) 2007 239
24. P.Y. Scarabin Haemostatic variables and arterial thrombotic disease: epidemiological evidence M.J. Seghatchian, Hypercoagulable States: Fundamental Aspects, Acquired Disorders and Congenital Thrombophilia 1996 CRC Press 209 216
25. E. Oger, M. Alhenc-Gelas, K. Lacut, M.T. Blouch, N. Roudaut, V. Kerlan, M. Collet, J.F. Abgrall, M. Aiach, P.Y. Scarabin, and D. Mottier Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial Arterioscler. Thromb. Vasc. Biol. 23 9 2003 1671 1676
26. M. Canonico Hormone therapy and hemostasis among postmenopausal women: a review Menopause 21 July (7) 2014 753 762
27. M. Canonico, G. Plu-Bureau, G.D. Lowe, and P.Y. Scarabin Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis BMJ 336 May (7655) 2008 1227 1231
28. E. Hoibraaten, E. Qvigstad, H. Arnesen, S. Larsen, E. Wickstrom, and P.M. Sandset Increased risk of recurrent venous thromboembolism during hormone replacement therapy-results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET) Thromb. Haemost. 84 December (6) 2000 961 967
29. M. Cushman, L.H. Kuller, R. Prentice, R.J. Rodabough, B.M. Psaty, R.S. Stafford, S. Sidney, and F.R. Rosendaal Estrogen plus progestin and risk of venous thrombosis JAMA 292 October (13) 2004 1573 1580
30. J.D. Curb, R.L. Prentice, P.F. Bray, R.D. Langer, L. Van Horn, V.M. Barnabei, M.J. Bloch, M.G. Cyr, M. Gass, L. Lepine, R.J. Rodabough, S. Sidney, G.I. Uwaifo, and F.R. Rosendaal Venous thrombosis and conjugated equine estrogen in women without a uterus Arch. Intern. Med. 166 April (7) 2006 772 780
31. C. Straczek, M. Alhenc-Gelas, M.L. Aubry, and P.Y. Scarabin Genetic variation at the estrogen receptor alpha locus in relation to venous thromboembolism risk among postmenopausal women J. Thromb. Haemost. 3 July (7) 2005 1535 1537
32. M. Canonico, E. Oger, J. Conard, G. Meyer, H. Levesque, N. Trillot, M.T. Barrellier, D. Wahl, J. Emmerich, and P.Y. Scarabin Estrogen, group THRS obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER study J. Thromb. Haemost. 4 June (6) 2006 1259 1265
33. V. Olie, G. Plu-Bureau, J. Conard, M.H. Horellou, M. Canonico, and P.Y. Scarabin Hormone therapy and recurrence of venous thromboembolism among postmenopausal women Menopause 18 May (5) 2011 488 493
34. P.Y. Scarabin Hormone therapy and venous thromboembolism among postmenopausal women Front. Horm. Res. 43 2014 21 32
35. M. Canonico, M. Alhenc-Gelas, G. Plu-Bureau, V. Olie, and P.Y. Scarabin Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen Menopause 17 November-December (6) 2010 1122 1127